REZORSTOBART
UNII Q3SE2QPZ2H

Substance Identification & Data

This profile provides standardized clinical and technical data for Rezorstobart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q3SE2QPZ2H.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2762201-86-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Q3SE2QPZ2H

CAS Registry Number

2762201-86-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

REZORSTOBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C199611

National Cancer Institute reference terminology for clinical and research data.

INN ID

12766

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

Rezorstobart

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rezorstobart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Rezorstobart

Common Names & Synonyms

Immunoglobulin G1 [301-alanine,de-C-terminal-lysine], anti-(human CD161 antigen) (human monoclonal IMT-009 γ1-chain), disulfide with human monoclonal IMT-009 κ-chain, dimer

immunoglobulin G1-kappa, anti-[Homo sapiens KLRB1 (killer cell lectin like receptor B1, NKR-P1A, natural killer cell surface protein P1A, CLEC5B, CD161)], Homo sapiens monoclonal antibody; gamma1 heavy chain Homo sapiens (1-450) [VH (Homo sapiens IGHV3-23*01 (96.9%) -(IGHD) -IGHJ4*01 (85.7%), Q120>R (113), CDR-IMGT [8.8.14] (26-33.51-58.97-110)) (1-121) -Homo sapiens IGHG1*01, G1m17,1 CH1 K120, CH3 D12, L14, G1v29 CH2 A84.4 (CH1 K120 (218) (122-219), hinge 1-15 (220-234), CH2 G1v29 CH2 N84.4>A (301) (235-344), CH3 D12 (360), L14 (362) (345-449), CHS K2>del (450)) (122-450)], (224-214')-disulfide with kappa light chain Homo sapiens (1'-214') [V-KAPPA (Homo sapiens IGKV1-12*01 (94.7%) -IGKJ4*01 (91.7%), CDR-IMGT [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo sapiens IGKC*01 (100%), Km3, A45.1 (153'), V101 (191') (108'-214')]; dimer (230-230'':233-233'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-K1 lacking the glutamine synthetase (GS-KO) gene, non-glycosylated

rezorstobart [INN]